U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776353) titled 'Understanding New Cachexia Subtypes Through Observational Epidemiological Research' on Aug. 17.
Brief Summary: The UNCOVER study is a longitudinal observational cohort focused on patients at high risk for cancer cachexia. At Kaiser Permanente Northern California, up to 800 individuals with advanced or unresectable non-small cell lung cancer, pancreatic adenocarcinoma, or colorectal cancer will be enrolled, as these malignancies carry a substantial risk of cancer cachexia, which is characterized by progressive loss of weight, muscle, and adipose tissue, accompanied by functional decline and reduced quality of life. Data collected inc...